Lack of Effect of Lovastatin on Restenosis after Coronary Angioplasty

Abstract
Experimental and clinical observations suggest that lowering serum lipid levels may reduce the risk of restenosis after coronary angioplasty. We report the results of a prospective, randomized, double-blind trial evaluating whether lowering lipid levels with lovastatin can prevent or delay restenosis after angioplasty.

This publication has 34 references indexed in Scilit: